<HTML><HEAD><TITLE>DOR BioPharma's S-8</TITLE><!-- Licensed to: DOR BioPharma--><!-- Document Created using EDGARIZER HTML --><!-- Copy Right 2003 EDGARfilings, Ltd., an IEC company.--><!-- All rights reserved EDGARfilings.com -->
<META content="MSHTML 6.00.2800.1400" name=GENERATOR></HEAD>
<BODY style="MARGIN-LEFT: 2.5%; MARGIN-RIGHT: 2.5%">
<DIV><BR>
<DIV></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">As filed with the Securities and Exchange Commission on September 9, 2004</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=right><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">Registration No. 333- &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 15.95pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman, serif">SECURITIES AND EXCHANGE COMMISSION</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">Washington, D.C. 20549</FONT> </DIV>
<TABLE cellSpacing=0 cellPadding=0 width="100%" align=center border=0>
<TR>
<TD align=middle width="21%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 10pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center>&nbsp;</DIV></TD></TR>
<TR>
<TD vAlign=top width="21%">
<HR width="100%" noShade SIZE=2>
</TD></TR></TABLE>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 15.95pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman, serif">FORM S-8</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">REGISTRATION STATEMENT</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">Under</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">The Securities Act of 1933</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 15.95pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><BR></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 18.2pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 16pt; FONT-FAMILY: Times New Roman, serif">DOR BioPharma, Inc.</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">(Exact name of registrant as specified in its charter)</FONT> </DIV>
<TABLE cellSpacing=0 cellPadding=0 width="100%" align=center border=0>
<TR>
<TD vAlign=top align=middle width="35%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">Delaware</FONT> <FONT style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">(State or other jurisdiction of</FONT> <FONT style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">of incorporation or organization)</FONT> </DIV></TD>
<TD vAlign=top align=middle width="40%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">41-1505029</FONT> <FONT style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">(IRS Employer</FONT> <FONT style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">Identification Number)</FONT> </DIV></TD></TR></TABLE>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><BR></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">1691 Michigan, Suite 435, Miami, Florida 33139</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">(Address of Principal Executive Offices including Zip Code)</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><BR></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">DOR BioPharma, Inc. Amended and Restated 1995 Omnibus Incentive Plan</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">(Full title of plans)</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><BR></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Geoff Green </FONT></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">President and Acting Chief Executive Officer </FONT></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">DOR BioPharma, Inc.</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">1691 Michigan, Suite 435, Miami, Florida 33139</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">(305) 534-3383</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">(Name, address and telephone number of agent for service)</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><BR></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">Copy to:</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><BR></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">MARK D. WOOD, ESQ.</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">Katten Muchin Zavis Rosenman</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">525 West Monroe Street, Suite 1600</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">Chicago, Illinois 60661-3693</FONT> </DIV>
<TABLE cellSpacing=0 cellPadding=0 width="100%" align=center border=0>
<TR>
<TD align=middle width="21%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 20.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center>&nbsp;</DIV></TD></TR>
<TR>
<TD vAlign=top width="21%">
<HR width="100%" noShade SIZE=2>
</TD></TR></TABLE>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><BR></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, serif">CALCULATION OF REGISTRATION FEE</FONT> </DIV>
<TABLE cellSpacing=0 cellPadding=0 width="100%" align=center border=0>
<TR>
<TD vAlign=top align=middle width="28%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 9.1pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman, serif">Title of securities to be registered</FONT> </DIV></TD>
<TD vAlign=top align=middle width="14%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 9.1pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman, serif">Amount to be registered (1)</FONT> </DIV></TD>
<TD vAlign=top align=middle width="15%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 9.1pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman, serif">Proposed maximum</FONT> <FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman, serif">offering price per</FONT> <FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman, serif">share (2)</FONT> </DIV></TD>
<TD vAlign=top align=middle width="16%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 9.1pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman, serif">Proposed maximum</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 9.1pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman, serif">aggregate offering</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 9.1pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman, serif">price (2)</FONT> </DIV></TD>
<TD vAlign=top align=middle width="13%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 9.1pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman, serif">Amount of</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 9.1pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman, serif">registration fee</FONT> </DIV></TD></TR>
<TR>
<TD vAlign=top width="28%">
<HR width="100%" noShade SIZE=2>
</TD>
<TD vAlign=top width="14%">
<HR width="100%" noShade SIZE=2>
</TD>
<TD vAlign=top width="15%">
<HR width="100%" noShade SIZE=2>
</TD>
<TD vAlign=top width="16%">
<HR width="100%" noShade SIZE=2>
</TD>
<TD vAlign=top width="13%">
<HR width="100%" noShade SIZE=2>
</TD></TR>
<TR>
<TD vAlign=top align=left width="28%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 9.1pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman, serif">Common Stock, $0.001 par value</FONT> </DIV></TD>
<TD vAlign=top align=middle width="14%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 9.1pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman, serif">5,282,743 </FONT><FONT style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman, serif">shares</FONT> </DIV></TD>
<TD vAlign=top align=middle width="15%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 9.1pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman, serif">$0.48</FONT> </DIV></TD>
<TD vAlign=top align=middle width="16%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 9.1pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman, serif">$2,535,717</FONT> </DIV></TD>
<TD vAlign=top align=middle width="13%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 9.1pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman, serif">$380.10</FONT> </DIV></TD></TR>
<TR>
<TD vAlign=top width="28%">
<HR width="100%" noShade SIZE=2>
</TD>
<TD vAlign=top width="14%">
<HR width="100%" noShade SIZE=2>
</TD>
<TD vAlign=top width="15%">
<HR width="100%" noShade SIZE=2>
</TD>
<TD vAlign=top width="16%">
<HR width="100%" noShade SIZE=2>
</TD>
<TD vAlign=top width="13%">
<HR width="100%" noShade SIZE=2>
</TD></TR></TABLE>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 10.5pt; FONT-FAMILY: Times New Roman, serif"></FONT>&nbsp;</DIV>
<OL compact>
<LI>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 10.5pt; FONT-FAMILY: Times New Roman, serif">This registration statement also covers an indeterminate number of additional shares of Common Stock that may be issued by reason of stock splits, stock dividends or similar transactions pursuant to Rule 416(a) of the Securities Act of 1933, as amended.</FONT> </DIV>
<LI>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 10.5pt; FONT-FAMILY: Times New Roman, serif">Calculated solely for purposes of this offering under Rule 457(h) of the Securities Act of 1933, as amended, on the basis of the average of the high and low selling prices per share of DOR BioPharma&#146;s Common Stock on September 3, 2004 as reported by the American Stock Exchange.</FONT> </DIV></LI></OL><BR>
<DIV></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><BR></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 13.65pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Introduction</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 13.65pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><BR></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify><FONT id=TAB1 style="MARGIN-LEFT: 36pt"></FONT><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">This Registration Statement on Form S-8 (the "Registration Statement") registers additional securities of the same class as other securities for which registration statements on Form S-8 relating to the DOR BioPharma, Inc. Amended and Restated 1995 Omnibus Incentive Plan are effective. In accordance with General Instruction E to Form S-8, DOR BioPharma, Inc. (the "Company") incorporates by reference the contents of the Company&#146;s registration statement on Form S-8, Filing No. 333-64035, filed with the Securities and Exchange Commission (the "Commission") on September 23, 1998, the Company&#146;s registration statement on Form S-8, Registration File No. 333-69286, filed with the Commission on September 12, 2001, and the Company&#146;s registration statement on Form S-8, Registration File No. 333-75366, filed with the Commission on December 18, 2001.</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 13.65pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify><BR></DIV>
<TABLE id=PGBRK cellSpacing=0 cellPadding=0 width="100%" border=0>
<TR>
<TD vAlign=bottom width="100%" colSpan=3>&nbsp;</TD></TR>
<TR>
<TD align=left width="33%"><FONT size=1>&nbsp;</FONT></TD>
<TD align=middle width="33%"><FONT size=1>&nbsp;</FONT></TD>
<TD align=right width="33%"><FONT size=1>&nbsp;</FONT></TD></TR>
<TR>
<TD colSpan=3><FONT size=1>
<HR width="100%" noShade SIZE=1>
</FONT></TD></TR>
<TR>
<TD vAlign=bottom width="100%" colSpan=3>&nbsp;</TD></TR></TABLE>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 13.65pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify><BR></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">PART II </FONT><BR><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Information Required in the Registration Statement </FONT><BR></DIV><BR>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif"><STRONG>Item 8.</STRONG> </FONT><FONT id=TAB2 style="COLOR: black; LETTER-SPACING: 41.5pt">&nbsp; &nbsp;</FONT>&nbsp;<FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif; TEXT-DECORATION: underline">Exhibits</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left>&nbsp;</DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif"></FONT>&nbsp;</DIV>
<TABLE cellSpacing=0 cellPadding=0 width="100%" align=center border=0>
<TR>
<TD align=left width="16%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Exhibit Number</FONT> <FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif"></FONT></DIV></TD>
<TD align=left width="64%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 144pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman, serif">Exhibit</FONT> </DIV></TD></TR>
<TR>
<TD vAlign=top width="16%">
<HR width="100%" noShade SIZE=2>
</TD>
<TD vAlign=top width="64%"></TD></TR>
<TR>
<TD align=left width="16%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">&nbsp; 4.1</FONT> </DIV></TD>
<TD align=left width="64%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Amended and Restated Certificate of Incorporation, incorporated by reference from Exhibit 3.1 to the registrant&#146;s quarterly report on Form 10-QSB for the quarter ended September 30, 2003. </FONT></DIV></TD></TR>
<TR>
<TD align=left width="16%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">&nbsp; 4.2</FONT> </DIV></TD>
<TD align=left width="64%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Amended and Restated Bylaws of the Company, incorporated by reference from Exhibit 3.1 to the registrant&#146;s quarterly report on Form 10-QSB for the quarter ended June 30, 2003. </FONT></DIV></TD></TR>
<TR>
<TD align=left width="16%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">&nbsp; 4.3</FONT> </DIV></TD>
<TD align=left width="64%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">DOR BioPharma, Inc. Amended and Restated 1995 Omnibus Incentive Plan, as amended, incorporated by reference from Exhibit 10.1 to the registrant&#146;s quarterly report on Form 10-QSB for the quarter ended September 30, 2003.</FONT> </DIV></TD></TR>
<TR>
<TD align=left width="16%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">&nbsp; 5.1</FONT> </DIV></TD>
<TD align=left width="64%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Opinion of Katten Muchin Zavis Rosenman, as to the legality of the securities being registered (including consent).</FONT> </DIV></TD></TR>
<TR>
<TD align=left width="16%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">23.1</FONT> </DIV></TD>
<TD align=left width="64%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Consent of Sweeney, Gates &amp; Co., registered public accounting firm. </FONT></DIV></TD></TR>
<TR>
<TD align=left width="16%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">23.2</FONT> </DIV></TD>
<TD align=left width="64%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Consent of Katten Muchin Zavis Rosenman (included in Exhibit 5.1).</FONT> </DIV></TD></TR>
<TR>
<TD align=left width="16%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">24.1</FONT> </DIV></TD>
<TD align=left width="64%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Power of Attorney (included on the signature page hereto).</FONT> </DIV></TD></TR></TABLE>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify><BR></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><BR></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><BR></DIV><BR>
<DIV></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif; TEXT-DECORATION: underline">SIGNATURES</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center>&nbsp;</DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Pursuant to the requirements of the Securities Act of 1933, the</FONT> <FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif"></FONT><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Company certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Miami, State of Florida, on this 8th day of September 2004</FONT> <FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">.</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify>&nbsp;</DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify>&nbsp;</DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 180pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">DOR BIOPHARMA, INC.</FONT><BR><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">By:</FONT><FONT id=TAB2 style="COLOR: black; LETTER-SPACING: 28pt">&nbsp;&nbsp;</FONT>&nbsp;/<U>s/ Geoff Green&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </U></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 180pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT id=TAB2 style="COLOR: black; LETTER-SPACING: 28pt"><FONT id=TAB2 style="LETTER-SPACING: 18pt">&nbsp;&nbsp;</FONT>&nbsp;</FONT>&nbsp;<FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Geoff Green</FONT><BR><FONT id=TAB2 style="COLOR: black; LETTER-SPACING: 28pt">&nbsp; &nbsp;</FONT>&nbsp;<FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">President and Acting Chief Executive Officer</FONT><BR><FONT id=TAB2 style="COLOR: black; LETTER-SPACING: 28pt">&nbsp; &nbsp;</FONT>&nbsp;<FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">(principal executive officer)</FONT><BR></DIV><BR>
<TABLE id=PGBRK cellSpacing=0 cellPadding=0 width="100%" border=0>
<TR>
<TD vAlign=bottom width="100%" colSpan=3>&nbsp;</TD></TR>
<TR>
<TD align=left width="33%"><FONT size=1>&nbsp;</FONT></TD>
<TD align=middle width="33%"><FONT size=1>&nbsp;</FONT></TD>
<TD align=right width="33%"><FONT size=1>&nbsp;</FONT></TD></TR>
<TR>
<TD colSpan=3><FONT size=1>
<HR width="100%" noShade SIZE=1>
</FONT></TD></TR>
<TR>
<TD vAlign=bottom width="100%" colSpan=3>&nbsp;</TD></TR></TABLE>
<DIV style="DISPLAY: block; MARGIN-LEFT: 216pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><BR></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">POWER OF ATTORNEY</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><BR></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Each person whose signature appears below hereby constitutes and appoints Geoff Green and or William Milling, and each of them severally, acting alone and without the other, his or her true and lawful attorneys-in-fact and agents, with full power of substitution, to sign on his or her behalf, individually and in each capacity stated below, all amendments and post-effective amendments to this registration statement on Form S-8 and to file the same, with all exhibits thereto and any other documents in connection therewith, with the Securities and Exchange Commission under the Securities Act of 1933, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully and to all intents and purposes as each might or could do in person, hereby ratifying and confirming each act that said attorneys-in-fact and agents may lawfully do or cause to be done by virtue thereof. </FONT></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif"></FONT>&nbsp;</DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Pursuant to the requirements of the 1933 Act, this registration statement has been signed below on September 09, 2004 by the following persons in the capacities indicated.</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 13.65pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify><BR></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify>
<TABLE cellSpacing=0 cellPadding=0 width="100%" align=center bgColor=#ffffff border=0>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>/s/&nbsp;Geoff Green</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>President and Acting Chief Executive Officer (principal executive officer)</FONT></TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%">
<HR SIZE=1>
</TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%">
<HR SIZE=1>
</TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>Geoff Green</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2></FONT></TD></TR></TABLE></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify>
<TABLE cellSpacing=0 cellPadding=0 width="100%" align=center bgColor=#ffffff border=0>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>/s/&nbsp;William D. Milling</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>Controller, Treasurer and Corporate Secretary (principal accounting officer)</FONT></TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%">
<HR SIZE=1>
</TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%">
<HR SIZE=1>
</TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>William D. Milling</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2></FONT></TD></TR></TABLE></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify>
<TABLE cellSpacing=0 cellPadding=0 width="100%" align=center bgColor=#ffffff border=0>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>/s/&nbsp;Alexander M. Haig Jr.</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>Chairman of the Board</FONT></TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%">
<HR SIZE=1>
</TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%">
<HR SIZE=1>
</TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>Alexander M. Haig Jr.</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2></FONT></TD></TR></TABLE></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify>
<TABLE cellSpacing=0 cellPadding=0 width="100%" align=center bgColor=#ffffff border=0>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>/s/&nbsp;Steve Kanzer</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>Vice Chairman of the Board</FONT></TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%">
<HR SIZE=1>
</TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%">
<HR SIZE=1>
</TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>Steve Kanzer</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2></FONT></TD></TR></TABLE></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify>
<TABLE cellSpacing=0 cellPadding=0 width="100%" align=center bgColor=#ffffff border=0>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>/s/&nbsp;Peter Salomon</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>Director</FONT></TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%">
<HR SIZE=1>
</TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%">
<HR SIZE=1>
</TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>Peter Salomon</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2></FONT></TD></TR></TABLE></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify>
<TABLE cellSpacing=0 cellPadding=0 width="100%" align=center bgColor=#ffffff border=0>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>/s/ Lawrence Kessel</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>Director</FONT></TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%">
<HR SIZE=1>
</TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%">
<HR SIZE=1>
</TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>Lawrence Kessel</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2></FONT></TD></TR></TABLE></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify>
<TABLE cellSpacing=0 cellPadding=0 width="100%" align=center bgColor=#ffffff border=0>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>/s/&nbsp;Arthur Asher Kornbluth</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>Director</FONT></TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%">
<HR SIZE=1>
</TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%">
<HR SIZE=1>
</TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>Arthur Asher Kornbluth</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2></FONT></TD></TR></TABLE></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify>
<TABLE cellSpacing=0 cellPadding=0 width="100%" align=center bgColor=#ffffff border=0>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>/s/&nbsp;James S. Kuo</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>Director</FONT></TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%">
<HR SIZE=1>
</TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%">
<HR SIZE=1>
</TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>James S. Kuo</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2></FONT></TD></TR></TABLE></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify>
<TABLE cellSpacing=0 cellPadding=0 width="100%" align=center bgColor=#ffffff border=0>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>/s/&nbsp;Evan Myrianthopoulos</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>Director</FONT></TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%">
<HR SIZE=1>
</TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%">
<HR SIZE=1>
</TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>Evan Myrianthopoulos</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2></FONT></TD></TR></TABLE></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify>
<TABLE cellSpacing=0 cellPadding=0 width="100%" align=center bgColor=#ffffff border=0>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, serif" size=2>&nbsp;</FONT></TD></TR></TABLE></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify>
<TABLE cellSpacing=0 cellPadding=0 width="100%" align=center bgColor=#ffffff border=0>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT size=2>/s/ Stuart Sedlack</FONT></TD>
<TD width="5%"><FONT size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT size=2>Director</FONT></TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%">
<HR SIZE=1>
</TD>
<TD width="5%"><FONT size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT size=2>&nbsp;</FONT></TD>
<TD width="40%">
<HR SIZE=1>
</TD></TR>
<TR vAlign=top bgColor=#ffffff>
<TD width="40%"><FONT size=2>Stuart Sedlack</FONT></TD>
<TD width="5%"><FONT size=2>&nbsp;</FONT></TD>
<TD width="5%"><FONT size=2>&nbsp;</FONT></TD>
<TD width="40%"><FONT size=2></FONT></TD></TR></TABLE></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify><FONT id=TAB2 style="COLOR: black; LETTER-SPACING: 7.449pt"></FONT>&nbsp;</DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify><FONT style="COLOR: black; LETTER-SPACING: 7.449pt">&nbsp;&nbsp;&nbsp;</FONT>&nbsp;<FONT id=TAB2 style="COLOR: black; LETTER-SPACING: 28pt">&nbsp;&nbsp;&nbsp;</FONT>&nbsp;<FONT id=TAB2 style="COLOR: black; LETTER-SPACING: 28pt">&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify><FONT id=TAB1 style="MARGIN-LEFT: 36pt"></FONT><FONT id=TAB1 style="MARGIN-LEFT: 18pt"></FONT></DIV>
<TABLE id=PGBRK cellSpacing=0 cellPadding=0 width="100%" border=0>
<TR>
<TD vAlign=bottom width="100%" colSpan=3>&nbsp;</TD></TR>
<TR>
<TD align=left width="33%"><FONT size=1>&nbsp;</FONT></TD>
<TD align=middle width="33%"><FONT size=1>&nbsp;</FONT></TD>
<TD align=right width="33%"><FONT size=1>&nbsp;</FONT></TD></TR>
<TR>
<TD colSpan=3><FONT size=1>
<HR width="100%" noShade SIZE=1>
</FONT></TD></TR>
<TR>
<TD vAlign=bottom width="100%" colSpan=3>&nbsp;</TD></TR></TABLE>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify><BR></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify><BR></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif; TEXT-DECORATION: underline">EXHIBIT INDEX</FONT> </DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center>&nbsp;</DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center>&nbsp;</DIV>
<TABLE cellSpacing=0 cellPadding=0 width="100%" align=center border=0>
<TR>
<TD align=left width="16%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Exhibit Number</FONT> <FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif"></FONT></DIV></TD>
<TD align=left width="64%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 144pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman, serif">Exhibit</FONT> </DIV></TD></TR>
<TR>
<TD vAlign=top width="16%">
<HR width="100%" noShade SIZE=2>
</TD>
<TD vAlign=top width="64%"></TD></TR>
<TR>
<TD align=left width="16%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">&nbsp; 5.1</FONT> </DIV></TD>
<TD align=left width="64%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Opinion of Katten Muchin Zavis Rosenman, as to the legality of the securities being registered (including consent).</FONT> </DIV></TD></TR>
<TR>
<TD align=left width="16%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">23.1</FONT> </DIV></TD>
<TD align=left width="64%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Consent of Sweeney, Gates &amp; Co., registered public accounting firm. </FONT></DIV></TD></TR>
<TR>
<TD align=left width="16%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">23.2</FONT> </DIV></TD>
<TD align=left width="64%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Consent of Katten Muchin Zavis Rosenman (included in Exhibit 5.1).</FONT> </DIV></TD></TR>
<TR>
<TD align=left width="16%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">24.1</FONT> </DIV></TD>
<TD align=left width="64%">
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><FONT style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, serif">Power of Attorney (included on the signature page hereto).</FONT> </DIV></TD></TR></TABLE>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.5pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=justify><FONT id=TAB1 style="MARGIN-LEFT: 36pt"></FONT></DIV>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=left><BR></DIV>
<TABLE id=LASTFTR width="100%" border=0>
<TR>
<TD vAlign=bottom width="100%" colSpan=3>
<DIV style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 11.35pt; MARGIN-RIGHT: 0pt; WHITE-SPACE: pre" align=center><BR></DIV></TD></TR>
<TR>
<TD align=left width="33%"><FONT size=1>&nbsp;</FONT></TD>
<TD align=middle width="33%"><FONT size=1>&nbsp;</FONT></TD>
<TD align=right width="33%"><FONT size=1>&nbsp;</FONT></TD></TR></TABLE></DIV></BODY></HTML>
[{"type": "S-8", "sequence": "1", "filename": "dors-8.htm", "description": "DOR BIOPHARMA'S S-8", "secsgml_size_bytes": 55195}]
{"company-data": {"conformed-name": "DOR BIOPHARMA INC", "cik": "0000812796", "assigned-sic": "2834", "irs-number": "411505029", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-118895", "film-number": "041023856"}, "business-address": {"street1": "1691 MICHIGAN AVE.", "street2": "SUITE 435", "city": "MIAMI", "state": "FL", "zip": "33139", "phone": "305-534-3383"}, "mail-address": {"street1": "1691 MICHIGAN AVE.", "street2": "SUITE 435", "city": "MIAMI", "state": "FL", "zip": "33139"}, "former-company": [{"former-conformed-name": "ENDOREX CORP", "date-changed": "19960916"}, {"former-conformed-name": "IMMUNOTHERAPEUTICS INC", "date-changed": "19920703"}]}
DOR BioPharma's S-8
As filed with the Securities and Exchange Commission on September 9, 2004
Registration No. 333-
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
Under
The Securities Act of 1933
DOR BioPharma, Inc.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of
of incorporation or organization)
41-1505029
(IRS Employer
Identification Number)
1691 Michigan, Suite 435, Miami, Florida 33139
(Address of Principal Executive Offices including Zip Code)
DOR BioPharma, Inc. Amended and Restated 1995 Omnibus Incentive Plan
(Full title of plans)
Geoff Green
President and Acting Chief Executive Officer
DOR BioPharma, Inc.
1691 Michigan, Suite 435, Miami, Florida 33139
(305) 534-3383
(Name, address and telephone number of agent for service)
Copy to:
MARK D. WOOD, ESQ.
Katten Muchin Zavis Rosenman
525 West Monroe Street, Suite 1600
Chicago, Illinois 60661-3693
CALCULATION OF REGISTRATION FEE
Title of securities to be registered
Amount to be registered (1)
Proposed maximum
offering price per
share (2)
Proposed maximum
aggregate offering
price (2)
Amount of
registration fee
Common Stock, $0.001 par value
5,282,743
shares
$0.48
$2,535,717
$380.10
This registration statement also covers an indeterminate number of additional shares of Common Stock that may be issued by reason of stock splits, stock dividends or similar transactions pursuant to Rule 416(a) of the Securities Act of 1933, as amended.
Calculated solely for purposes of this offering under Rule 457(h) of the Securities Act of 1933, as amended, on the basis of the average of the high and low selling prices per share of DOR BioPharma's Common Stock on September 3, 2004 as reported by the American Stock Exchange.
Introduction
This Registration Statement on Form S-8 (the "Registration Statement") registers additional securities of the same class as other securities for which registration statements on Form S-8 relating to the DOR BioPharma, Inc. Amended and Restated 1995 Omnibus Incentive Plan are effective. In accordance with General Instruction E to Form S-8, DOR BioPharma, Inc. (the "Company") incorporates by reference the contents of the Company's registration statement on Form S-8, Filing No. 333-64035, filed with the Securities and Exchange Commission (the "Commission") on September 23, 1998, the Company's registration statement on Form S-8, Registration File No. 333-69286, filed with the Commission on September 12, 2001, and the Company's registration statement on Form S-8, Registration File No. 333-75366, filed with the Commission on December 18, 2001.
PART II
Information Required in the Registration Statement
Item 8.
Exhibits
Exhibit Number
Exhibit
4.1
Amended and Restated Certificate of Incorporation, incorporated by reference from Exhibit 3.1 to the registrant's quarterly report on Form 10-QSB for the quarter ended September 30, 2003.
4.2
Amended and Restated Bylaws of the Company, incorporated by reference from Exhibit 3.1 to the registrant's quarterly report on Form 10-QSB for the quarter ended June 30, 2003.
4.3
DOR BioPharma, Inc. Amended and Restated 1995 Omnibus Incentive Plan, as amended, incorporated by reference from Exhibit 10.1 to the registrant's quarterly report on Form 10-QSB for the quarter ended September 30, 2003.
5.1
Opinion of Katten Muchin Zavis Rosenman, as to the legality of the securities being registered (including consent).
23.1
Consent of Sweeney, Gates & Co., registered public accounting firm.
23.2
Consent of Katten Muchin Zavis Rosenman (included in Exhibit 5.1).
24.1
Power of Attorney (included on the signature page hereto).
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
Company certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Miami, State of Florida, on this 8th day of September 2004
.
DOR BIOPHARMA, INC.
By:
/
s/ Geoff Green
Geoff Green
President and Acting Chief Executive Officer
(principal executive officer)
POWER OF ATTORNEY
Each person whose signature appears below hereby constitutes and appoints Geoff Green and or William Milling, and each of them severally, acting alone and without the other, his or her true and lawful attorneys-in-fact and agents, with full power of substitution, to sign on his or her behalf, individually and in each capacity stated below, all amendments and post-effective amendments to this registration statement on Form S-8 and to file the same, with all exhibits thereto and any other documents in connection therewith, with the Securities and Exchange Commission under the Securities Act of 1933, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully and to all intents and purposes as each might or could do in person, hereby ratifying and confirming each act that said attorneys-in-fact and agents may lawfully do or cause to be done by virtue thereof.
Pursuant to the requirements of the 1933 Act, this registration statement has been signed below on September 09, 2004 by the following persons in the capacities indicated.
/s/ Geoff Green
President and Acting Chief Executive Officer (principal executive officer)
Geoff Green
/s/ William D. Milling
Controller, Treasurer and Corporate Secretary (principal accounting officer)
William D. Milling
/s/ Alexander M. Haig Jr.
Chairman of the Board
Alexander M. Haig Jr.
/s/ Steve Kanzer
Vice Chairman of the Board
Steve Kanzer
/s/ Peter Salomon
Director
Peter Salomon
/s/ Lawrence Kessel
Director
Lawrence Kessel
/s/ Arthur Asher Kornbluth
Director
Arthur Asher Kornbluth
/s/ James S. Kuo
Director
James S. Kuo
/s/ Evan Myrianthopoulos
Director
Evan Myrianthopoulos
/s/ Stuart Sedlack
Director
Stuart Sedlack
EXHIBIT INDEX
Exhibit Number
Exhibit
5.1
Opinion of Katten Muchin Zavis Rosenman, as to the legality of the securities being registered (including consent).
23.1
Consent of Sweeney, Gates & Co., registered public accounting firm.
23.2
Consent of Katten Muchin Zavis Rosenman (included in Exhibit 5.1).
24.1
Power of Attorney (included on the signature page hereto).